MediWound Ltd. announced the appointment of Roland Frösing as the company's European Medical Director in support of its planned advancement of the EscharEx program for the debridement of chronic wounds as well as its efforts to expand market access and reimbursement for NexoBrid. Before joining the company, Roland served as Global Medical Director and head of Market Access at Mölnlycke Health Care, where he led the global medical development and market access activities worldwide.